Mood and Diabetes Empowerment & Improvement Training (MADE-IT)
University of California, Los Angeles (UCLA)/Drew Project EXPORT: Mood and Diabetes Empowerment & Improvement Training (MADE IT)
연구 개요
상세 설명
The Phase I pilot recruited older Latinos from Dr. Mangione's previous study (who agreed to participate in future research) and 10 participants from a community settings. Those with low mood and poor glycemic control were offered a 12-week intervention combining cognitive behavioral therapy mood management techniques and diabetes self-care into one seamless intervention. Drs. Mangione and Miranda supervised and reviewed (through audiotapes) well-trained health educators conducting the intervention sessions. The study manuals were modified following this Phase I pilot intervention.
The final intervention manual was tested in a randomized trial in Phase II, compared the Mood and Diabetes Empowerment and Improvement Training intervention with enhanced care as usual (providing participants with a letter regarding their mood and hemoglobin (Hb)A1c with recommendations for improving care for their provider). The target population was low-income Latinos with depression and poor glycemic control. Both mood and diabetes outcomes are evaluated.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
California
-
Los Angeles, California, 미국, 90095
- UCLA Psychr & Biobehav Sci
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Latino men and women age 50 and older
- Must speak English or Spanish
- Hb A1c greater than or equal to 8%
- Currently not taking medication for depression
- A score of 5 or greater on the Geriatric Depression Scale (GDS)
Exclusion Criteria:
- Persons who are legally blind, dialysis dependent, diagnosed with dementia, and/or with hemiparesis from a cerebral vascular accident
- Do not have sufficient hearing or cognitive function
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
간섭 없음: Wait-listed Control Group
Participants in the Wait-listed Control Group will receive augmented access and communication with a primary care provider.
The augmentation would consist of providing the participant with a letter to be shared with their primary care doctor indicating their Hb A1c level and depression score at the time of eligibility screening.
The research team will also attach a list of local mental health service providers to the letter.
The participants randomized to the wait-listed control group will also be offered access to the intervention after the trial is completed in the event that the randomized controlled trial (RCT) has significant results.
|
|
|
실험적: Empowerment and CBT Classes
Participants will attend weekly 2-hour group Empowerment and CBT classes for 12 weeks led by two trained health educators.
Participants will learn cognitive behavioral therapy (CBT) techniques to manage their mood.
After CBT, participants will learn a diabetes education format that is grounded in empowerment theory that employs group problem solving, individualized goal setting, and personal behavioral change "experiments" designed to help patients set priorities and to become better self-managers of both diabetes and their mood.
As part of the intervention activities, group members will be advised to monitor their blood sugar levels, blood pressure, and mood on a daily basis.
|
Participants randomized to the intervention arm will receive a manual with 3 CBT modules and 1 Diabetes Empowerment module.
CBT Module 1 covers "Understanding Depression and Diabetes", Module 2 "How Thoughts Affect Your Mood and Diabetes Care", Module 3 "How Activities Affect Your Mood and Diabetes Care".
The Diabetes Empowerment Module covers topics including the following: food, exercise, medicine, diabetes and your health, social support, communication skills, and community resources.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change From Baseline in Hemoglobin A1c at 6 Months
기간: Baseline and 6 months
|
Hemoglobin A1c (HbA1c) measures glycemic control over the past three months.
HbA1c was measured by a blood draw and laboratory test.
|
Baseline and 6 months
|
|
Change From Baseline in Depression Measures at 6 Months
기간: Baseline and 6 months
|
The Geriatric Depression Scale (GDS) measures depression in older adults. The short form we used consists of 15 yes or no questions. The scale range is 0 to 15, where higher scores indicate greater severity of depression. The Patient Health Questionnaire-9 (PHQ-9) measures depression in patients. The questionnaire consists of 9 questions where patients self report how frequently they have depression symptoms over the past two weeks. The scale ranges is 0 to 27 where higher scores indicate greater severity of depression. |
Baseline and 6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change From Baseline in Blood Pressure at 6 Months
기간: Baseline and 6 months
|
Baseline and 6 months
|
|
|
Change From Baseline in Low Density Lipoprotein-C at 6 Months
기간: Baseline and 6 months
|
Baseline and 6 months
|
|
|
Change From Baseline in EQ-5D at 6 Months
기간: Baseline and 6 months
|
The EQ-5D measures general quality of life. The index score is based on 5 questions about mobility, self-care, pain, usual activities, and psychological status. The EuroQol Group provides a U.S. preference-weighted algorithm to calculate the index scores. A score of 1 indicates no problems while a score of -0.11 indicates severe problems. The scale score is based on a visual analog of a thermostat, where 0 represents worst imaginable health and 100 represents best imaginable health. Patients mark a tick for where they feel their health is on that scale. |
Baseline and 6 months
|
|
Change From Baseline in Yale Physical Activity Scale - Index Summary Score at 6 Months
기간: Baseline and 6 months
|
The Yale Physical Activity Scale measures physical function and activities of daily living.
Five activity indices (vigorous activity, leisurely walking, moving, standing and sitting) are calculated by multiplying the frequency of activity with the duration and a weighted factor.
The 5 indices are then summed to create an index summary.
Higher scores indicate more activity.
The minimum and maximum scores are 0 and 142.
|
Baseline and 6 months
|
|
Change From Baseline in Self-Efficacy (Diabetes Empowerment Scale) at 6 Months
기간: Baseline and 6 months
|
The Diabetes Empowerment Scale Short Form (DES-SF) measures diabetes-related psychosocial self-efficacy.
The questionnaire presents 8 statements on self-efficacy where participants rate how strongly they agree.
The answers are summed to create a score where higher scores indicate more empowerment.
The score range is 0 to 8.
|
Baseline and 6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Jeanne Miranda, PhD, UCLA Psychr & Biobehav Sci
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
제2형 당뇨병에 대한 임상 시험
-
Postgraduate Institute of Medical Education and...완전한
-
Hangzhou SynRx Therapeutics Biomedical Technology...모병유방암 | 난소 암 | 고급 고형 종양 | 전이성 고형 종양 | BRCA 1/2 및/또는 HRD중국
Empowerment and CBT Classes에 대한 임상 시험
-
The University of Texas Health Science Center,...완전한
-
Charite University, Berlin, GermanyGerman Federal Ministry of Education and Research완전한